2009-012529-12: A randomised, REQUIP® IR-controlled, n-of-1, multiple crossover, pilot trial of the effect of REQUIP®CR on abnormal daytime somnolence in patients with Parkinson’s Disease |
|
|
| Ongoing | 4 | 10 | Europe | ropinirole, REQUIP-LP, REQUIP, REQUIP-LP, REQUIP | CHU de Toulouse | parkinson\'s disease | | | | |
2012-000801-64: A study of the effects of medication on memory in Parkinson\'s Disease |
|
|
| Ongoing | 4 | 55 | Europe | Pramipexole dihydrochloride monohydrate extended release, Ropinirole hydrochloride prolonged release, N/A, Mirapexin extended release various strengths, Requip prolonged release, Mirapexin extended release various strengths, Requip prolonged release | University Hospital of North Staffordshire, Keele University, National Institute for Health Research | Idiopathic Parkinson\'s Disease | | | | |
2009-013004-31: Early combined prolonged release ropinirole and rasagiline therapy in newly diagnosed patients with Parkinsons disease. A prospective, randomized, parallel groups, long-term follow-up study including delayed-start design of rasagiline |
|
|
| Ongoing | 3 | 150 | Europe | Tablet, Prolonged-release tablet | UNIVERSITA, DEGLI STUDI DI PARMA | Patients with Parkinson, s diesease | | | | |
